Improvements in the understanding of lung cancer genomics have led to the identification of major driver mutations genes, including EGFR, KRAS, ALK, BRAF, HER2, PIK3CA, AKT1, MAP2K1, and MET [12,13]. This evidence concerns the gene KRAS and lung carcinoma.